Growth Metrics

Skinvisible (SKVI) EPS (Basic) (2016 - 2025)

Skinvisible (SKVI) has disclosed EPS (Basic) for 16 consecutive years, with -$0.05 as the latest value for Q4 2025.

  • Quarterly EPS (Basic) fell 162.5% to -$0.05 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$0.2 through Dec 2025, down 81.82% year-over-year, with the annual reading at -$0.2 for FY2025, 81.82% down from the prior year.
  • EPS (Basic) hit -$0.05 in Q4 2025 for Skinvisible, roughly flat from -$0.05 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.08 in Q4 2024 to a low of -$0.33 in Q1 2023.
  • Historically, EPS (Basic) has averaged -$0.07 across 5 years, with a median of -$0.06 in 2021.
  • Biggest five-year swings in EPS (Basic): crashed 560.0% in 2023 and later surged 233.33% in 2024.
  • Year by year, EPS (Basic) stood at -$0.04 in 2021, then crashed by 125.0% to -$0.09 in 2022, then soared by 33.33% to -$0.06 in 2023, then soared by 233.33% to $0.08 in 2024, then crashed by 162.5% to -$0.05 in 2025.
  • Business Quant data shows EPS (Basic) for SKVI at -$0.05 in Q4 2025, -$0.05 in Q3 2025, and -$0.05 in Q2 2025.